Reverb Therapeutics raised $12 million in a seed round led by Amplitude Ventures to advance its Amplify•R™ platform for treating life-threatening diseases.
Amount Raised
$12 Million
Round Type
Seed
VancouverBiotechnologyHealth CareTherapeuticsInvestors
Description
Reverb Therapeutics announced the closure of a $12 million financing round, with Amplitude Ventures leading the investment. The funding will support the development of its Amplify•R™ platform aimed at modulating cytokine actions to treat cancer and autoimmune diseases.
Quick answer
Reverb Therapeutics raised $12 Million in a Seed round, dated February 19, 2025. Investors: Amplitude Ventures, Seido Capital, Finchley Healthcare Ventures, KDT Ventures, InBC Investment Corp. and Myeloma Investment Fund. Reverb Therapeutics is based in Vancouver, British Columbia, Canada.
- How much did Reverb Therapeutics raise?
- Reverb Therapeutics raised $12 Million in a Seed round on February 19, 2025.
- Who invested in Reverb Therapeutics?
- Amplitude Ventures, Seido Capital, Finchley Healthcare Ventures, KDT Ventures, InBC Investment Corp. and Myeloma Investment Fund are named as investors in this round.
- What does Reverb Therapeutics do?
- Reverb Therapeutics is a leader in creating precision medicine by harnessing the body’s immune system and endogenous cytokines.
- Where is Reverb Therapeutics based and how big is it?
- Reverb Therapeutics is based in Vancouver, British Columbia, Canada. Fundz records about 10 employees.
- Who are the decision-makers at Reverb Therapeutics?
- Fundz holds 1 contact at Reverb Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Reverb Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Apeximmune Therapeutics raised $21M (Series A) on April 1, 2025.
- Prazer Therapeutics raised $22M (Series B) on April 1, 2025.
- NewcelX raised $2M (Seed) on March 28, 2025.
- Epicrispr Biotechnologies raised $68M (Series B) on March 27, 2025.
- Surrozen raised $76M on March 26, 2025.
- Tribune Therapeutics raised $40M (Seed) on March 26, 2025.
Who to call at Reverb Therapeutics, and when
A new round usually means Reverb Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Reverb Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Reverb Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Reverb Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Reverb Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Reverb Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.